Bulletin
Investor Alert

Novo Nordisk A/S ADR

NYS: NVO

GO
/marketstate/country/us

After Hours

NVO
/zigman2/quotes/203484366/composite

$

101.04

Change

-0.73 -0.72%

Volume

Volume 5,387

Sep 21, 2021, 5:33 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203484366/composite

Today's close

$ 99.66

$ 101.77

Change

+2.11 +2.12%

Day low

Day high

$100.88

$102.43

Open
Open: 100.88

52 week low

52 week high

$63.22

$107.24

Open

Market cap

$227.28B

Average volume

1.10M

P/E ratio

33.16

Rev. per Employee

$428,322

EPS

3.07

Dividend

0.55

Div yield

1.03%

Ex dividend date

8/16/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nvo

MarketWatch News on NVO

  1. The Bull Case for Walmart’s Insulin Products

    12:08 p.m. Aug. 12, 2021

    - Barron's Online

  2. European Dividends Are on the Mend After a Pandemic Slashing

    6:53 p.m. July 6, 2021

    - Barron's Online

  3. Walmart to launch lower-priced insulin offering savings of up to 75%

    9:03 a.m. June 29, 2021

    - Wallace Witkowski

  4. European stocks struggle at the end of the week

    10:15 a.m. June 25, 2021

    - Barbara Kollmeyer

  5. These Activists Look for Ways That ESG Can Enhance Returns

    9:30 p.m. June 11, 2021

    - Barron's Online

  6. European stocks head toward record high, led by Adidas and Siemens

    10:58 a.m. May 7, 2021

    - Barbara Kollmeyer

  7. Novo Nordisk lifts guidance and boosts buybacks

    2:05 a.m. May 5, 2021

    - MarketWatch.com

  8. The FDA Is Clamping Down. What to Know.

    7:16 a.m. March 29, 2021

    - Barron's Online

  9. European stocks gain, led by Adidas after upbeat results

    10:55 a.m. March 10, 2021

    - Barbara Kollmeyer

  10. European stocks claw back territory after strong U.S. jobs data

    10:44 a.m. March 5, 2021

    - Barbara Kollmeyer

  11. Diabetes drug hailed as a breakthrough for weight loss

    4:51 p.m. Feb. 11, 2021

    - Barbara Kollmeyer

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nvo

Other News on NVO

  1. Mawer Investment Management 2Q 2021 Summary

    11:40 a.m. Sept. 20, 2021

    - Seeking Alpha

  2. The 10 Richest People on Wall Street and How to Invest in Them

    12:38 p.m. Sept. 10, 2021

    - InvestorPlace.com

  3. Here's Why Novo Nordisk (NVO) is a Strong Growth Stock

    9:09 a.m. Sept. 9, 2021

    - Zacks.com

  4. Nicholas Ward's Dividend Growth Portfolio: August 2021 Update

    9:27 p.m. Sept. 8, 2021

    - Seeking Alpha

  5. This Could Mean Moderna and BioNTech Are Actually Dirt Cheap

    6:50 a.m. Sept. 3, 2021

    - Motley Fool

  6. 4 Blue Chip Bargains In The Biopharma Space

    9:14 p.m. Sept. 1, 2021

    - Seeking Alpha

  7. Novo Nordisk: Dominance In The Diabetes Market

    9:33 a.m. Sept. 1, 2021

    - Seeking Alpha

  8. Should You Follow Jim Simons’ Lead and Jump on AMC Stock?

    8:00 a.m. Aug. 24, 2021

    - InvestorPlace.com

  9. 3 Big Drug/Biotech Outperformers Worth Keeping an Eye On

    9:24 a.m. Aug. 18, 2021

    - Zacks.com

  10. 3 Low-Risk Stocks for Conservative Investors

    6:35 a.m. Aug. 17, 2021

    - Motley Fool

  11. Eli Lilly And Company: Great Business, Horrible Investment

    8:43 a.m. Aug. 13, 2021

    - Seeking Alpha

  12. Horizon Therapeutics Will Offer Above Average Returns

    3:17 p.m. Aug. 12, 2021

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/nvo

Press Releases on NVO

  1. Women's Health Market To Witness Huge Growth By 2026 : Bayer, Pfizer, Merck

    6:10 p.m. July 29, 2021

    - Market Insight Reports

  2. Rhythm Pharmaceuticals Announces Senior Leadership Additions

    8:11 a.m. July 29, 2021

    - GlobeNewswire

  3. Biologics Market geographies Trends and Prospects by 2025

    7:45 a.m. July 29, 2021

    - Market Insight Reports

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.